EVOK - Evoke Pharma Inc
11
0.040 0.364%
Share volume: 47,105
Last Updated: 12-16-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$10.96
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-07-2024 | 03-13-2025 | 05-13-2025 | 08-14-2025 | 11-13-2025 | |
| Total revenue | 1.735 M | 2.551 M | 2.654 M | 3.308 M | 3.080 M | 3.752 M | 4.284 M | |
| Cost of revenue | 92.529 K | 41.478 K | 104.024 K | 118.500 K | 41.613 K | 167.679 K | 101.977 K | |
| Gross profit | 1.643 M | 2.510 M | 2.550 M | 3.190 M | 3.039 M | 3.584 M | 4.182 M | |
| 52.77% | 1.60% | 25.09% | -4.74% | 17.97% | 16.67% | |||
| Operating expenses | 3.144 M | 3.733 M | 3.836 M | 4.384 M | 4.340 M | 5.143 M | 5.320 M | |
| Selling general and admin | 3.140 M | 3.733 M | 3.824 M | 4.384 M | 4.298 M | 5.135 M | 5.314 M | |
| Research and development | 4.645 K | 0.000 | 11.677 K | 0.000 | 42.783 K | 8.413 K | 5.320 K | |
| Total expenses | 3.144 M | 3.733 M | 3.836 M | 4.384 M | 4.340 M | 5.143 M | 5.320 M | |
| 18.74% | 2.74% | 14.28% | -0.99% | 18.50% | 3.43% | |||
| Operating income | -1.501 M | -1.224 M | -1.286 M | -1.194 M | -1.302 M | -1.559 M | -1.138 M | |
| Ebit | -1.501 M | -1.224 M | -1.286 M | -1.194 M | -1.306 M | -1.571 M | -1.138 M | |
| Pretax income | -1.580 M | -1.267 M | -1.312 M | -1.193 M | -1.311 M | -1.583 M | -1.156 M | |
| -19.79% | 3.56% | -9.11% | 9.88% | 20.79% | -26.97% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.580 M | -1.267 M | -1.312 M | -1.193 M | -1.306 M | -1.571 M | -1.156 M | |
| 19.79% | -3.56% | 9.11% | -9.51% | -20.27% | 26.40% |